Q2/26 in Line; 2026E Outlook Reiterated

Research evidence excerpt

Q2/26 in Line; 2026E Outlook Reiterated

e

to Editorial Department, BMO Capital Markets, 151 West 42nd St, 33rd Floor, New York, NY 10036 or Editorial Department, BMO Capital Markets,

1 First Canadian Place, Toronto, Ontario, M5X 1H3.

Dissemination of Research

Dissemination of fundamental BMO Capital Markets Equity Research is available via our website https://research.bmo.com. Institutional clients

may also simultaneously receive our fundamental research via email and/or via services such as Refinitiv, Bloomberg, FactSet, Visible Alpha,

and S&P Capital IQ.

BMO Capital Markets issues a variety of research products in addition to fundamental research. Institutional clients may request notification

when additional research content is made available on our website. BMO Capital Markets may use proprietary models in the preparation of

reports. Material information about such models may be obtained by contacting the research analyst directly. There is no planned frequency

of model updates.

The analyst(s) named in this report may discuss trading strategies that reference a catalyst or event that may have a near or long term impact

on the market price of the equity securities discussed. In some cases, the impact may directionally counter the analyst’s published 12 month

target price and rating. Any such trading or alternative strategies can be based on differing time horizons, methodologies, or otherwise and are

distinct from and do not affect the analysts' fundamental equity rating in the report.

Research coverage of licensed cannabis producers and other cannabis-related companies is made available only to eligible approved North

American, Australian, and EU-based BMO Nesbitt Burns Inc., BMO Capital Markets Limited, Bank of Montreal Europe Plc and BMO Capital Markets

Corp.